Literature DB >> 17907163

The role of interleukin-1 and the inflammasome in gout: implications for therapy.

Richard M Pope1, Jürg Tschopp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17907163     DOI: 10.1002/art.22938

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  62 in total

1.  Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes.

Authors:  Wan-Tai Dang; Wen-Guang Xie; Jing-Guo Zhou
Journal:  Chin J Integr Med       Date:  2017-10-30       Impact factor: 1.978

2.  NOD2/CARD15 gene mutations in patients with gouty arthritis.

Authors:  Ahmet Karaarslan; Senol Kobak; Afig Berdeli
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

Review 3.  The challenges of gout management in the elderly.

Authors:  Lisa K Stamp; Sarah Jordan
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

4.  Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease.

Authors:  Luca Liberale; Fabrizio Montecucco; Jean-Claude Tardif; Peter Libby; Giovanni G Camici
Journal:  Eur Heart J       Date:  2020-08-14       Impact factor: 29.983

5.  Study on the expressions of NLRP3 gene transcript variants in peripheral blood monocytes of primary gout patients.

Authors:  Wantai Dang; Dan Xu; Wenguang Xie; Jingguo Zhou
Journal:  Clin Rheumatol       Date:  2018-06-26       Impact factor: 2.980

6.  Prevalence and significance of MEFV gene mutations in patients with gouty arthritis.

Authors:  Ahmet Karaarslan; Senol Kobak; Işın Kaya; Nazım Intepe; Mehmet Orman; Afig Berdelı
Journal:  Rheumatol Int       Date:  2016-09-01       Impact factor: 2.631

7.  Macrophage-derived IL-1β enhances monosodium urate crystal-triggered NET formation.

Authors:  Payel Sil; Haley Wicklum; Chandler Surell; Balázs Rada
Journal:  Inflamm Res       Date:  2016-11-16       Impact factor: 4.575

8.  NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis.

Authors:  C Guo; R Fu; S Wang; Y Huang; X Li; M Zhou; J Zhao; N Yang
Journal:  Clin Exp Immunol       Date:  2018-09-16       Impact factor: 4.330

Review 9.  IL-1beta processing in host defense: beyond the inflammasomes.

Authors:  Mihai G Netea; Anna Simon; Frank van de Veerdonk; Bart-Jan Kullberg; Jos W M Van der Meer; Leo A B Joosten
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

10.  The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study.

Authors:  R Terkeltaub; J S Sundy; H R Schumacher; F Murphy; S Bookbinder; S Biedermann; R Wu; S Mellis; A Radin
Journal:  Ann Rheum Dis       Date:  2009-07-26       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.